Tango Therapeutics
Oncology Therapeutics · Precision Medicine

Tango Therapeutics: Products & infrastructure

Tango Therapeutics has 8 clinical trials on record, 6 under way.

Data updated Nov 21, 2026 · Back to the company report

Products

Tango Therapeutics has 8 clinical trials on record, 6 under way.

8clinical trials
6trials under way
1EU trials (CTIS)
EU clinical trialsthe trials it sponsors, per the EU's CTIS register
A Phase 1/2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Anti-tumor Activity o…
Phase I and Phase II (Integrated)- First administration to humans · "Ph1: •Locally advanced (LA) or metastatic MTAP-deleted (me… · France
Oct 2024
Clinical trialsthe studies it sponsors or works on, per ClinicalTrials.gov
TNG462-C103: Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Vopimetostat in Combination With ERA…
phase 2 · under way · 188 participants · PDAC; PDAC - Pancreatic Ductal Adenocarcinoma; NSCLC; RAS Mutation
Nov 2026
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
phase 2 · under way · 183 participants · PDAC; PDAC - Pancreatic Ductal Adenocarcinoma; NSCLC; RAS Mutation
May 2025
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
phase 2 · under way · 191 participants · Non Small Cell Lung Cancer; Glioma Glioblastoma Multiforme; Glioma, Malignant; …
Mar 2025
S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deleti…
phase 2 · under way · 61 participants · as a collaborator · MTAP-deleted Solid Tumors
Apr 2024
Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors
phase 2 · stopped or withdrawn · 7 participants · Breast Cancer; Ovarian Cancer; Pancreas Cancer; Prostate Cancer
Dec 2023
Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors
phase 2 · under way · 126 participants · Non Small Cell Lung Cancer; Solid Tumors, Adult; Lung Cancer; Lung Adenocarcino…
Jun 2023
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
phase 2 · under way · 225 participants · Locally Advanced Solid Tumor
May 2023
Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors
phase 2 · stopped or withdrawn · 110 participants · Locally Advanced Solid Tumor
Mar 2022
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.